Since its proposal, the Model for End-Stage Liver Disease (MELD) score has been employed to predict short-term mortality among patients with chronic liver disease and those awaiting liver ...
As it has been clearly shown that waiting time is not an accurate marker of waiting list mortality, [27] the “sickest first” policy has been widely adopted for organ allocation, with the aim of ...
MELD 3.0 is superior to other MELD-based scores for long-term prognostication in hospitalized patients with cirrhosis, while GEMA-Na demonstrated even more accurate and better performance. The ...
Although there have been no prospective studies that assess the usefulness of preoperative risk assessment with either the CTP or MELD scores, the published data provide a basis for general ...
Adoption of a new version of the Model for End-Stage Liver Disease, known as MELD 3.0, closed the gap in access to liver transplant between men and women, an analysis showed. Since MELD 3.0 was ...
Rochester, Minn.-based Mayo Clinic developed an artificial intelligence model using electrocardiogram data that outperformed the current model for end-stage liver disease score in predicting severe ...
A team of researchers from Boston-based Harvard Medical School, Boston-based Massachusetts General Hospital and IBM Research developed a risk score to predict patient outcomes after cirrhosis-related ...
Since the adoption of a new model for assessing the severity of liver disease, women are more likely to be added to the waitlist for a liver transplant, more likely to receive a transplant, and less ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results